HANGZHOU, ZHEJIANG, CHINA, January 16, 2026 /EINPresswire.com/ -- The pharmaceutical industry is undergoing a period of ...

SAN FRANCISCO, CA, UNITED STATES, January 13, 2026 /EINPresswire.com/ -- Bringing together public institutions, ...

A key insight from the whitepaper is the increasing divergence in verification expectations between regions. While the EU ...

A surge in Inventiva shares, up about 50% in the first few weeks of 2026, highlights investors' appetite for ​betting on the ...

Over the past five years, Novavax ( NVAX 6.01%), a vaccine maker, lost more than 90% of its market value. Though it succeeded ...

Jan 30 () - CSPC Pharmaceutical Group ​said on ‌Friday it had ‌entered an agreement with UK drugmaker AstraZeneca for ⁠the ...

Delve into what 2026 has to offer in the biotech industry. The market is showing signs it's picking up and the patent cliff ...

On January 26, UBS lifted its price target on Amgen Inc. (NASDAQ:AMGN) to $390 from $380 and kept a Buy rating on the stock.

There might be massive upside ahead for these drugmakers.

In an agreement that seemingly bodes well for the flow of pharmaceuticals between the two regions, the EU and India on Monday agreed to a sweeping free trade agreement that the European bloc has ...

Teva Pharmaceutical ADR saw its IBD SmartSelect Composite Rating rise to 98 Thursday, up from 92 the day before.

Brazil’s health regulator Anvisa has recalled medicine batches and seized falsified products over packaging irregularities ...